Indian system of medicine used concurrently with standard conventional medicine improves quality of life in patients of cardio vascular diseases (C.V.D)

Authors

  • Dr Pamila Dua Department of Pharmacology, All India Institute of Medical Sciences, New Delhi 110 029, India
  • Dr Sandeep Seth Department of Cardiology, All India Institute of Medical Sciences, New Delhi 110 029, India
  • Dr Ravindra Mohan Pandey Department of Biostatistics, All India Institute of Medical Sciences, New Delhi 110 029, India
  • Dr Subir Kumar Maulik Department of Pharmacology, All India Institute of Medical Sciences, New Delhi 110 029, India

DOI:

https://doi.org/10.56042/ijtk.v22i2.36672

Keywords:

Cardiovascular disorders, Con-current, Indian System of Medicine, Quality of life

Abstract

Worldwide there is increased shift towards usage of traditional medicine in patients of chronic diseases like Cardio
Vascular Disorders. In India, these medicines are used concurrently. Objective of the study was to ascertain prevalence and
effect of concurrent traditional drug therapy with standard pharmacotherapy in patients with CVD. The present study used a
cross sectional study design to assess the prevalence and a prospective cohort design to assess the effect of concurrent
Ayurvedic medicines with standard pharmacotherapy in terms of quality of life. After screening 600 patients, 128 were
found taking such medicines. Out of these, 100 were recruited as cases (Group-I), while 100 who were matched in terms of
age, body mass index, ejection fraction, and receiving standard therapy only were recruited as controls (Group-II).
Assessment parameters included demographic, biochemical, ejection fraction through echocardiography, distance covered in
six Minute walk Test (6MWT), Quality of Life (QOL) through Kansas City Cardio-myopathy Questionnaire (KCCQ) and
Seattle Angina Questionnaire (SAQ) with follow up at 6 months. Prakriti as mentioned in Ayurveda was also assessed using
a questionnaire. Both groups were comparable at base line. Total 87 in Group-I and 91 in Group-II completed the study.
Further, 76% patients were diagnosed with heart failure (HF) and 24% with coronary artery disease (CAD). There was no
change in distance covered in 6MWT in both HF or CAD groups. But there was improvement in all cases in domains of
KCCQ and SAQ as compared to controls. To conclude, concurrent use of traditional medicine with standard conventional
care in CVD may improve quality of life in cardiovascular disorders.

Downloads

Published

2023-06-28